Top

Familial Cancer

Published in:

01-04-2003

Attenuated familial adenomatous polyposis (AFAP): a review of the literature

Authors: Anne Lyster Knudsen, Marie Luise Bisgaard, Steffen Bülow

Published in: Familial Cancer | Issue 1/2003

Title: Attenuated familial adenomatous polyposis (AFAP): a review of the literature
Authors: Anne Lyster Knudsen
Marie Luise Bisgaard
Steffen Bülow
Publication date: 01-04-2003
Publisher: Kluwer Academic Publishers
Published in: Familial Cancer / Issue 1/2003
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1023/A:1023286520725

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2003

Instructions for authors

The effect of disease penetrance, family size, and age of onset on family history with application to setting eligibility criteria for genetic testing

Genetic susceptibility to prostate cancer: a review

The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours

Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features

Keynote webinar | Spotlight on antibody–drug conjugates in cancer